Healthcode’s invoice data reveals an increase in insurer-funded oncology. Director of strategic partnerships and external affairs Richard Aris, looks at the possible reasons and what this means for patients From AI-driven advances in the research and diagnosis of cancer to the development of new personalised, targeted treatments, this is an exciting moment in the battle…
Join thousands of sector professionals

©2026 All rights reserved LaingBuisson

